Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia
Titel:
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia
Auteur:
Miners, John O. Chau, Nuy Rowland, Andrew Burns, Kushari McKinnon, Ross A. Mackenzie, Peter I. Tucker, Geoffrey T. Knights, Kathleen M. Kichenadasse, Ganessan